NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is accelerating its push…
Safe Pro Group (NASDAQ: SPAI), an AI-driven defense and security solutions provider, received a new order from a U.S. Government…
The $400M at-the-market equity offering was completed in just over two weeks. The average sale price in the offering was…
Nutriband (NASDAQ: NTRB) is reminding shareholders of its upcoming 25% preferred stock dividend. Shareholders of record as of July 25,…
ONAR’s 79% year-over-year revenue growth in Q1 2025 reflects its strategic shift toward high-value, recurring marketing services Recent restructuring and…
SEGG Media (NASDAQ: SEGG, LTRYW), released further details on its strategic investment in Veloce Media Group, including Veloce’s July 12,…
Recent data indicates Soligenix’s HyBryte(TM) is showing promising treatment success in early-stage cutaneous T-cell lymphoma. “With limited treatment options, especially…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharma company focused on treating brain and CNS cancers, will implement a 1-for-12 reverse stock…
Family offices, privately held wealth management firms for affluent families, are increasingly investing in sports franchises, seeing them as long-term…
Fifty 1 Labs (OTC: FITY) announced a strategic partnership and intent to acquire Vancouver-based BioSpark AI Technologies Inc., a leader…